insights_auto
Why is IONS down 5.24%?
Dive Deeperchevron_right
IONS:NASDAQ
Ionis Pharmaceuticals Inc
$41.24
arrow_downward
-5.24%(-2.28) 1D
$41.56
arrow_upward
+0.78% (+0.32)bedtimeAfter hours
Closed: Nov 2, 4:00:02 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IONS...
Open
$43.66
High
$43.91
Low
$41.19
Mkt. cap
6.85B
Avg. vol.
3.11M
Volume
2.56M
52-wk high
$86.74
52-wk low
$41.19
EPS
-$3.47
Beta
0.38
Shares outstanding
166.18M
No. of employees
1K
Open
$43.66
High
$43.91
Low
$41.19
Mkt. cap
6.85B
Avg. vol.
3.11M
Volume
2.56M
52-wk high
$86.74
52-wk low
$41.19
EPS
-$3.47
Beta
0.38
Shares outstanding
166.18M
No. of employees
1K
News stories
From web sources and news partners
BioSpace
·
4 minutes ago
Ionis to hold third quarter 2026 financial results webcast
Investing.com UK
·
12 hours ago
Ionis Pharmaceuticals stock hits 52-week low at 42.08 USD By Investing.com
Yahoo Finance
·
1 month ago
Failure of Novartis’ Pelacarsen Could Reshape the Lp(a) Race for CRISPR and Ionis
Profile
Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015. Wikipedia
About Ionis Pharmaceuticals Inc
CEOBrett P. Monia Ph.D.
Employees1.48K
Founded1989
HeadquartersCarlsbad, California, United States
SectorBiotechnology
Websiteionis.com